Piotr Ponikowski Selected Research

ferric carboxymaltose

1/2022	Responder analysis for improvement in 6-min walk test with ferric carboxymaltose in patients with heart failure with reduced ejection fraction and iron deficiency.
1/2022	Health status improvement with ferric carboxymaltose in heart failure with reduced ejection fraction and iron deficiency.
10/2021	Ferric carboxymaltose for the treatment of iron deficiency in heart failure: a multinational cost-effectiveness analysis utilising AFFIRM-AHF.
9/2021	Intravenous ferric carboxymaltose does not provide benefits in reperfused acute myocardial infarction in the rat with normal iron status.
6/2021	The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study.
12/2020	Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.
12/2019	Rationale and design of the AFFIRM-AHF trial: a randomised, double-blind, placebo-controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron-deficient patients admitted for acute heart failure.
1/2018	Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis.
10/2017	Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency.
5/2016	Relation of Longitudinal Changes in Quality of Life Assessments to Changes in Functional Capacity in Patients With Heart Failure With and Without Anemia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Piotr Ponikowski Research Topics

Disease

363	Heart Failure 08/2022 - 04/2003
45	Iron Deficiencies 01/2022 - 01/2008
22	Cardiomyopathies (Cardiomyopathy) 01/2022 - 02/2007
21	Atrial Fibrillation 01/2022 - 01/2012
19	Dyspnea (Shortness of Breath) 01/2022 - 01/2010
17	Type 2 Diabetes Mellitus (MODY) 08/2022 - 02/2015
17	Renal Insufficiency (Renal Failure) 01/2020 - 04/2009
13	Myocardial Infarction 01/2022 - 01/2008
13	Stroke (Strokes) 12/2019 - 03/2012
12	Inflammation (Inflammations) 01/2022 - 06/2006
12	Systolic Heart Failure 01/2021 - 01/2009
11	Hypoxia (Hypoxemia) 01/2022 - 06/2013
10	Anemia 11/2021 - 02/2007
9	Chronic Renal Insufficiency 01/2022 - 05/2011
9	Hypotension (Low Blood Pressure) 01/2022 - 01/2017
9	Heart Diseases (Heart Disease) 03/2021 - 01/2011
8	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2003
8	Cardiovascular Diseases (Cardiovascular Disease) 11/2020 - 01/2011
8	Ischemic Stroke 10/2016 - 05/2012
7	Disease Progression 12/2021 - 10/2010
7	Hypertension (High Blood Pressure) 12/2019 - 08/2012
5	Tachycardia (Tachyarrhythmias) 01/2022 - 10/2013
5	Acute Coronary Syndrome 09/2021 - 01/2011
5	Central Sleep Apnea (Central Sleep Apnea Syndrome) 01/2021 - 01/2013
5	Weight Loss (Weight Reduction) 02/2016 - 05/2013
5	Hemorrhage 09/2015 - 05/2012
4	Neoplasms (Cancer) 01/2022 - 01/2011
4	Body Weight (Weight, Body) 01/2019 - 02/2007
4	Diabetes Mellitus 10/2017 - 09/2010
4	Obesity 01/2017 - 02/2007

Drug/Important Bio-Agent (IBA)

44	IronIBA 05/2022 - 01/2008
40	Biomarkers (Surrogate Marker)IBA 05/2022 - 09/2007
34	dapagliflozinIBA 08/2022 - 01/2019
27	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2021 - 11/2007
23	SodiumIBA 01/2022 - 03/2010
20	Natriuretic PeptidesIBA 01/2022 - 03/2006
20	ferric carboxymaltoseIBA 01/2022 - 11/2009
20	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 09/2005
18	vericiguatIBA 01/2022 - 09/2014
18	rolofyllineIBA 11/2019 - 01/2010
17	DiureticsIBA 01/2022 - 01/2010
17	empagliflozinIBA 01/2022 - 11/2017
15	Ferritins (Ferritin)IBA 05/2022 - 12/2009
15	Warfarin (Coumadin)FDA LinkGeneric 04/2019 - 05/2012
14	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2019 - 05/2012
13	Transferrin (beta 2 Transferrin)IBA 05/2022 - 12/2009
13	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 11/2017
13	CreatinineIBA 12/2019 - 03/2010
12	pro-brain natriuretic peptide (1-76)IBA 12/2021 - 09/2007
11	RelaxinIBA 12/2021 - 04/2009
10	Sodium-Glucose Transport ProteinsIBA 01/2022 - 11/2019
10	SymportersIBA 01/2022 - 11/2017
10	Testosterone (Sustanon)FDA Link 01/2021 - 01/2003
10	Purinergic P1 Receptor AntagonistsIBA 11/2019 - 01/2010
9	Hemoglobins (Hemoglobin)IBA 11/2021 - 02/2007
9	Soluble Guanylyl CyclaseIBA 10/2020 - 03/2013
9	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 08/2020 - 06/2004
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2007
8	NitrogenIBA 01/2022 - 01/2014
8	Mineralocorticoid Receptor AntagonistsIBA 01/2021 - 06/2012
7	Interleukin-6 (Interleukin 6)IBA 05/2022 - 03/2013
7	Oxygen (Dioxygen)IBA 01/2022 - 02/2007
7	Hormones (Hormone)IBA 06/2021 - 12/2009
7	Pharmaceutical PreparationsIBA 01/2021 - 01/2010
7	Urea (Carbamide)FDA LinkGeneric 01/2017 - 01/2014
7	Adenosine (Adenocard)FDA LinkGeneric 01/2017 - 04/2003
7	AndrogensIBA 12/2016 - 01/2009
6	Uric Acid (Urate)IBA 01/2022 - 04/2003
6	Atrial Natriuretic Factor (ANF)IBA 09/2016 - 11/2007
5	HepcidinsIBA 05/2022 - 01/2013
5	Transferrin Receptors (Transferrin Receptor)IBA 05/2022 - 05/2018
5	omecamtiv mecarbilIBA 01/2022 - 03/2016
5	Cardiac MyosinsIBA 01/2022 - 03/2016
5	Insulin (Novolin)FDA Link 01/2022 - 09/2005
5	AlbuminsIBA 06/2021 - 01/2014
5	AdrenomedullinIBA 01/2020 - 05/2010
5	PotassiumIBA 11/2019 - 06/2012
5	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 11/2019 - 06/2004
5	TroponinIBA 01/2019 - 08/2011
5	AnticoagulantsIBA 01/2019 - 01/2012
5	Adenosine A1 ReceptorIBA 01/2017 - 05/2011
5	Darbepoetin alfa (Aranesp)FDA Link 03/2012 - 02/2007
4	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 01/2017
4	Growth Differentiation Factor 15IBA 01/2022 - 09/2007
4	ReninIBA 12/2021 - 12/2019
4	Angiotensin Receptor AntagonistsIBA 01/2020 - 01/2017
4	Lactic Acid (Lactate)FDA LinkGeneric 01/2019 - 01/2018
4	IvabradineIBA 11/2017 - 03/2009
4	finerenoneIBA 07/2016 - 06/2012
4	Prostaglandins AIBA 05/2016 - 11/2013
4	Troponin T (Troponin T1)IBA 01/2016 - 11/2011

Therapy/Procedure

108	Therapeutics 08/2022 - 06/2004
22	Patient Readmission 11/2021 - 02/2012
15	Length of Stay 12/2020 - 01/2010
12	Drug Therapy (Chemotherapy) 01/2022 - 01/2008
5	Electric Countershock (Cardioversion) 01/2015 - 10/2012
4	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2022 - 08/2015
4	Heart Transplantation (Grafting, Heart) 11/2021 - 08/2012
4	Intravenous Infusions 01/2019 - 01/2013
4	Critical Care (Surgical Intensive Care) 01/2019 - 10/2008